It seem to me overwhelmingly that the CME selling TF to ICE would undermine the product because I remember only seeing negative responses all over the web by market participants about the CME doing such.
I believe this is more controlled by either CME or ICE winning the licensing bid from LSE.
http://www.reuters.com/article/cme-lse-ice-idUSL1N10E2JZ20150803